Tesamorelin holds FDA approval for HIV-associated lipodystrophy based on two Phase 3 RCTs (Falutz et al., 2007 and 2010) showing roughly 15 to 18 percent visceral adipose tissue reduction versus placebo at 26 weeks
Available as: Last cited 6 Sept 2023 Urva S, OFarrell L, Du Y, Loh MT, Hemmingway A, Qu H, Alsina-Fernandez J, Haupt A, Milicevic Z, Coskun T (2023) The novel GIP, GLP-1 and glucagon receptor agonist retatrutide delays gastric emptying
Mercodia GLP-1 (9-36) Amide Control Low, Medium, High (10-1287-01) is a three-level control for the Mercodia Total GLP-1 ELISA
Your hosts, Sal Di Stefano, Adam Schafer and Justin Andrews have over 50 years of combined fitness experience as personal trainers, club managers, IFBB fitness competitors and fitness thought leaders